Shenzhen Hepalink Pharmaceutical Group Co., Ltd. at its Annual General Meeting held on 22 May 2023 approved cash dividend of CNY 1.00000000 per 10 shares (tax included) for 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.98 CNY | -0.20% | -0.10% | -14.92% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.92% | 1.82B | |
+17.43% | 42.25B | |
+16.37% | 21.27B | |
+16.67% | 15.23B | |
+19.84% | 14.36B | |
+51.59% | 12.74B | |
-0.05% | 6.79B | |
-11.94% | 6.61B | |
-8.87% | 5.73B | |
+14.28% | 5.66B |
- Stock Market
- Equities
- 002399 Stock
- News Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
- Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Approves Cash Dividend for 2022